02/18/2026
đź’ˇ New research from Cleveland Clinic highlights the potential of combination preventive therapy to provide greater relief for patients with chronic migraine.
🔍 Key findings:
✔️ Dual therapy (Botox + anti-CGRP agents) may significantly reduce monthly migraine days compared to monotherapy.
✔️ A multifaceted approach could benefit patients who don’t respond to single-agent treatments.
✔️ Expanding evidence may shape future clinical guidelines and improve access to combination regimens.
Chronic migraine remains a leading cause of disability, but advancements like these offer hope for better outcomes and improved quality of life.
đź“– Read the full blog to learn more about these groundbreaking findings and their implications for migraine care!
https://hubs.li/Q0434yWq0